Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024;22(2):79-87.
doi: 10.2174/0115701611233184231206100222.

Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices

Affiliations
Review

Strategies to Minimize Access Site-related Complications in Patients Undergoing Transfemoral Artery Procedures with Large-bore Devices

Sabato Sorrentino et al. Curr Vasc Pharmacol. 2024.

Abstract

Large bore accesses refer to accesses with a diameter of 10 French or greater and are necessary for various medical devices, including those used in transcatheter aortic valve replacement, endovascular aneurysm repair stent-grafts, and percutaneous mechanical support devices. Notably, the utilization of these devices via femoral access is steadily increasing due to advancements in technology and implantation techniques, which are expanding the pool of patients suitable for percutaneous procedures. However, procedures involving large bore devices carry a high risk of bleeding and vascular complications (VCs), impacting both morbidity and long-term mortality. In this review article, we will first discuss the incidence, determinants, and prognostic impact of VCs in patients undergoing large bore access procedures. Subsequently, we will explore the strategies developed in recent years to minimize VCs, including techniques for optimizing vascular puncture through femoral cannulation, such as the use of echo-guided access cannulation and fluoroscopic guidance. Additionally, we will evaluate existing vascular closure devices designed for large bore devices. Finally, we will consider new pharmacological strategies aimed at reducing the risk of periprocedural access-related bleeding.

Keywords: Large bore access procedures; artery procedures; femoral access; long-term mortality.; morbidity; vascular complications.

PubMed Disclaimer

References

    1. Hengstenberg C.; Chandrasekhar J.; Sartori S.; Impact of pre-existing or new-onset atrial fibrillation on 30-day clinical outcomes following transcatheter aortic valve replacement: Results from the BRAVO 3 randomized trial. Catheter Cardiovasc Interv 2017,90(6),1027-1037 - DOI - PubMed
    1. Guedeney P.; Chieffo A.; Snyder C.; Impact of baseline atrial fibrillation on outcomes among women who underwent contemporary transcatheter aortic valve implantation (from the Win-TAVI Registry). Am J Cardiol 2018,122(11),1909-1916 - DOI - PubMed
    1. Sorrentino S.; Giustino G.; Moalem K.; Indolfi C.; Mehran R.; Dangas G.D.; Antithrombotic treatment after transcatheter heart valves implant. Semin Thromb Hemost 2018,44(1),38-45 - DOI
    1. Polimeni A.; Sorrentino S.; De Rosa S.; Transcatheter versus surgical aortic valve replacement in low-risk patients for the treatment of severe aortic stenosis. J Clin Med 2020,9(2),439 - DOI - PubMed
    1. Cheney A.E.; McCabe J.M.; Alternative percutaneous access for large bore devices. Circ Cardiovasc Interv 2019,12(6),e007707 - DOI

MeSH terms